Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Secondary prevention

Citations 421-430 of 568 total displayed.

Past content (since Feb 1999):

Correspondence
Low High-Density Lipoprotein Cholesterol and Response to Simvastatin Therapy in Scandinavian Simvastatin Survival Study (4S) Response
Sander Robins, Christie M. Ballantyne, Anders G. Olsson, Thomas J. Cook, Michele F. Mercuri, Terje R. Pedersen, and John Kjekshus
Circulation 2002;106:e8, doi:10.1161/01.CIR.0000019970.99823.B2 [Full text]  

Clinical Investigations and Reports
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment: The Losartan Intervention for Endpoint (LIFE) Study
Kristian Wachtell, Vittorio Palmieri, Michael H. Olsen, Eva Gerdts, Vasilios Papademetriou, Markku S. Nieminen, Gunnar Smith, Björn Dahlöf, Gerard P. Aurigemma, and Richard B. Devereux
Circulation 2002;106:227-232; published online before print as doi:10.1161/01.CIR.0000021601.49664.2A [Abstract] [Full text]  

Current Perspectives
Need to Test the Arterial Inflammation Hypothesis
Deepak L. Bhatt and Eric J. Topol
Circulation 2002;106:136-140, doi:10.1161/01.CIR.0000021112.29409.A2 [Full text]  

Articles
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment. The Losartan Intervention for Endpoint (LIFE) Study
Kristian Wachtell, Vittorio Palmieri, Michael H. Olsen, Eva Gerdts, Vasilios Papademetriou, Markku S. Nieminen, Gunnar Smith, Björn Dahlöf, Gerard P. Aurigemma, and Richard B. Devereux
Circulation published June 17, 2002, doi:10.1161/01.CIR.0000021601.49664.2A [Abstract]  

Editorials
Myocardial Infarct: No One Size Fits All
Marc A. Pfeffer and John J.V. McMurray
Circulation 2002;105:2577-2579, doi:10.1161/01.CIR.0000020729.75885.39 [Full text]  

Clinical Investigations and Reports
Prevention of Inflammation-Induced Endothelial Dysfunction: A Novel Vasculo-Protective Action of Aspirin
Rajesh K. Kharbanda, Benjamin Walton, Meredith Allen, Nigel Klein, Aroon D. Hingorani, Raymond J. MacAllister, and Patrick Vallance
Circulation 2002;105:2600-2604; published online before print as doi:10.1161/01.CIR.0000017863.52347.6C [Abstract] [Full text]  

Clinical Investigations and Reports
Tea Consumption and Mortality After Acute Myocardial Infarction
Kenneth J. Mukamal, Malcolm Maclure, James E. Muller, Jane B. Sherwood, and Murray A. Mittleman
Circulation 2002;105:2476-2481; published online before print as doi:10.1161/01.CIR.0000017201.88994.F7 [Abstract] [Full text]  

Clinical Investigations and Reports
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials: Prospective Pravastatin Pooling (PPP) Project
Marc A. Pfeffer, Anthony Keech, Frank M. Sacks, Stuart M. Cobbe, Andrew Tonkin, Robert P. Byington, Barry R. Davis, Carola P. Friedman, and Eugene Braunwald
Circulation 2002;105:2341-2346; published online before print as doi:10.1161/01.CIR.0000017634.00171.24 [Abstract] [Full text]  

Articles
Prevention of Inflammation-Induced Endothelial Dysfunction. A Novel Vasculo-Protective Action of Aspirin
Rajesh K. Kharbanda, Benjamin Walton, Meredith Allen, Nigel Klein, Aroon D. Hingorani, Raymond J. MacAllister, and Patrick Vallance
Circulation published May 13, 2002, doi:10.1161/01.CIR.0000017863.52347.6C [Abstract]  

AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Barbara V. Howard, Beatriz L. Rodriguez, Peter H. Bennett, Maureen I. Harris, Richard Hamman, Lewis H. Kuller, Thomas A. Pearson, and Judith Wylie-Rosett
Circulation 2002;105:e132-137e, doi:10.1161/01.CIR.0000013953.41667.09 [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

* Subspecialty Collections Home

* Show  Secondary prevention
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment